Literature DB >> 12888529

Establishment of conditional vectors for hairpin siRNA knockdowns.

Shiro Matsukura1, Peter A Jones, Daiya Takai.   

Abstract

Small interference RNA (siRNA) is an emerging methodology in reverse genetics. Here we report the development of a new tetracycline-inducible vector-based siRNA system, which uses a tetracycline-responsive derivative of the U6 promoter and the tetracycline repressor for conditional in vivo transcription of short hairpin RNA. This method prevents potential lethality immediately after transfection of a vector when the targeted gene is indispensable, or the phenotype of the knockdown is lethal or results in a growth abnormality. We show that the controlled knockdown of DNA methyltransferase 1 (DNMT1) in human cancer resulted in growth arrest. Removal of the inducer, doxycycline, from treated cells led to re-expression of the targeted gene. Thus the method allows for a highly controlled approach to gene knockdown.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888529      PMCID: PMC169962          DOI: 10.1093/nar/gng077

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  15 in total

1.  Expanding small RNA interference.

Authors:  Thomas Tuschl
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

2.  U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.

Authors:  Makoto Miyagishi; Kazunari Taira
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

3.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.

Authors:  Guangchao Sui; Christina Soohoo; El Bachir Affar; Frédérique Gay; Yujiang Shi; William C Forrester; Yang Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 4.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

5.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

6.  Effective expression of small interfering RNA in human cells.

Authors:  Cynthia P Paul; Paul D Good; Ira Winer; David R Engelke
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

7.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

8.  Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter.

Authors:  J Ohkawa; K Taira
Journal:  Hum Gene Ther       Date:  2000-03-01       Impact factor: 5.695

9.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

Review 10.  Mechanisms underlying expression of Tn10 encoded tetracycline resistance.

Authors:  W Hillen; C Berens
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

View more
  51 in total

1.  Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system.

Authors:  Xavier Coumoul; Wenmei Li; Rui-Hong Wang; Chuxia Deng
Journal:  Nucleic Acids Res       Date:  2004-06-15       Impact factor: 16.971

2.  Control of siRNA expression using the Cre-loxP recombination system.

Authors:  Vivi Kasim; Makoto Miyagishi; Kazunari Taira
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

Review 3.  Induction of RNA interference in dendritic cells.

Authors:  Mu Li; Hua Qian; Thomas E Ichim; Wei-Wen Ge; Igor A Popov; Katarzyna Rycerz; John Neu; David White; Robert Zhong; Wei-Ping Min
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 4.  RNA interference technologies for understanding and treating neurodegenerative diseases.

Authors:  Bingwei Lu
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 5.  Silence of the transcripts: RNA interference in medicine.

Authors:  Sailen Barik
Journal:  J Mol Med (Berl)       Date:  2005-07-19       Impact factor: 4.599

6.  TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain.

Authors:  Li-Ting Su; Maria A Agapito; Mingjiang Li; William T N Simonson; Anna Huttenlocher; Raymond Habas; Lixia Yue; Loren W Runnels
Journal:  J Biol Chem       Date:  2006-01-25       Impact factor: 5.157

7.  A retroviral vector for siRNA expression in mammalian cells.

Authors:  Gro Leite Størvold; Elisabet Gjernes; Hanne Arenberg Askautrud; Anne-Lise Børresen-Dale; Charles M Perou; Eirik Frengen
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

8.  A more efficient RNAi inducible system for tight regulation of gene expression in mammalian cells and xenograft animals.

Authors:  Jing Zhang; Cuiying Wang; Ning Ke; Josh Bliesath; John Chionis; Qiuchen S He; Qi-Xiang Li; Jon E Chatterton; Flossie Wong-Staal; Demin Zhou
Journal:  RNA       Date:  2007-07-06       Impact factor: 4.942

9.  A tightly regulated Pol III promoter for synthesis of miRNA genes in tandem.

Authors:  Hongxia Zhou; Cao Huang; Xu Gang Xia
Journal:  Biochim Biophys Acta       Date:  2008-04-07

10.  Therapeutic potential of RNA interference in pain medicine.

Authors:  Ping-Heng Tan; Lin-Cheng Yang; Ru-Rong Ji
Journal:  Open Pain J       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.